SCHEMBL25367285

SCHEMBL25367285

Cc1ccc(-c2ccc3c(c2)C(=O)C(=O)N3)cc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 5/20 0.74
MAOB P27338 5/20 0.74
PDE3B Q13370 2/20 0.70
PDE3A Q14432 2/20 0.70
SLC6A11 P48066 1/20 0.55
TGM2 P21980 5/20 0.55
CES1 P23141 5/20 0.55
ALDH1A1 P00352 1/20 0.54
ROS1 P08922 1/20 0.50
CDK5 Q00535 1/20 0.50
ACVR1 Q04771 1/20 0.50
LRRK2 Q5S007 1/20 0.50
CA12 O43570 1/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
CA9 Q16790 1/20 0.50
CAPN9 O14815 1/20 0.49
CASP3 P42574 1/20 0.49
CSNK1G1 Q9HCP0 1/20 0.47
BCHE P06276 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30588923 1.00 MAOA (0.74) MAOAMAOBPDE3BPDE3ASLC6A11
SCHEMBL27489766 0.89 MAOA (0.65) MAOAMAOBPDE3BPDE3ASLC6A11
SCHEMBL2789935 0.85 MAOA (1.00) MAOAMAOBPDE3BPDE3ASLC6A11
SCHEMBL29657257 0.84 ROS1 (0.67) MAOAMAOBPDE3BPDE3ATGM2
SCHEMBL281743 0.84 ROS1 (0.67) MAOAMAOBPDE3BPDE3ATGM2
SCHEMBL4370977 0.84 CES1 (0.73) MAOAMAOBPDE3BPDE3ASLC6A11
SCHEMBL29906173 0.84 MAOB (0.72) MAOAMAOBPDE3BPDE3ASLC6A11
SCHEMBL2788548 0.84 MAOB (0.72) MAOAMAOBPDE3BPDE3ASLC6A11
SCHEMBL2788213 0.83 MAOA (0.66) MAOAMAOBPDE3BPDE3ASLC6A11
SCHEMBL11213472 0.82 PDE3B (1.00) MAOAMAOBPDE3BPDE3ASLC6A11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230272401-A1 COMPOSITIONS FOR FLCN GENE MODULATION AND METHODS THEREOF Genetic Intelligence, Inc 2023-08-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230272401-A1 COMPOSITIONS FOR FLCN GENE MODULATION AND METHODS THEREOF TARDBP, FUS, RBM17 MAOA 4118/4885MAOB 3900/4885PDE3B 3551/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.